Virginie Desestret Selected Research

anti-Yo autoantibodies

1/2022	Immune and Genetic Signatures of Breast Carcinomas Triggering Anti-Yo-Associated Paraneoplastic Cerebellar Degeneration.
1/2018	Transcriptomic immune profiling of ovarian cancers in paraneoplastic cerebellar degeneration associated with anti-Yo antibodies.
1/2018	Complex HLA association in paraneoplastic cerebellar ataxia with anti-Yo antibodies.
1/2018	Genetic alterations and tumor immune attack in Yo paraneoplastic cerebellar degeneration.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Virginie Desestret Research Topics

Disease

13	Encephalitis (Encephalitis, Rasmussen) 01/2022 - 02/2014
12	Neoplasms (Cancer) 01/2022 - 12/2010
6	Autoimmune Diseases of the Nervous System 10/2018 - 05/2014
5	Glioma (Gliomas) 01/2022 - 12/2010
4	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 10/2021 - 01/2016
3	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 01/2018
3	Paraneoplastic Cerebellar Degeneration 01/2022 - 01/2018
3	Stroke (Strokes) 01/2013 - 05/2009
2	Temporal Lobe Epilepsy 07/2020 - 09/2002
2	Nervous System Diseases (Neurological Disorders) 01/2020 - 11/2019
2	Nervous System Paraneoplastic Syndromes 01/2020 - 11/2019
2	Tertiary Lymphoid Structures 11/2019 - 01/2018
2	Teratoma (Teratoid Tumor) 11/2019 - 12/2015
2	Seizures (Absence Seizure) 05/2018 - 01/2016
2	Cerebellar Ataxia (Dysmetria) 01/2018 - 07/2017
2	Anti-N-Methyl-D-Aspartate Receptor Encephalitis 10/2016 - 12/2015
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 05/2009 - 01/2007
1	Alzheimer Disease (Alzheimer's Disease) 01/2022
1	Leukocytosis (Pleocytosis) 10/2021
1	Cranial Nerve Diseases (Cranial Nerve Disorders) 01/2021
1	Paralysis (Palsy) 01/2021
1	Optic Nerve Diseases (Optic Neuropathy) 01/2021
1	Opsoclonus-Myoclonus Syndrome (Kinsbourne Syndrome) 01/2021
1	Mesothelioma 11/2019
1	Adenocarcinoma of Lung 04/2019
1	Inflammation (Inflammations) 04/2019
1	Mental Disorders (Mental Disorder) 05/2018
1	Cognitive Dysfunction 05/2018
1	Ovarian Neoplasms (Ovarian Cancer) 01/2018
1	Immune System Diseases (Immune Disorders) 01/2018
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2018
1	Ataxia (Dyssynergia) 07/2017
1	Dysarthria (Spastic Dysarthria) 07/2017
1	Anterograde Amnesia 01/2017
1	Asthenia 01/2017
1	Muscle Rigidity 10/2016
1	Mutism (Selective Mutism) 10/2016
1	Neurologic Manifestations (Neurological Manifestations) 10/2016
1	Rhabdomyolysis 10/2016
1	Coma (Comas) 10/2016
1	Thymoma (Thymic Carcinoma) 01/2016
1	Isaacs Syndrome (Neuromyotonia) 01/2016
1	Central Nervous System Diseases (CNS Diseases) 01/2016
1	Ovarian Teratoma 12/2015
1	Infectious Encephalitis 05/2014
1	Neoplasm Metastasis (Metastasis) 05/2013
1	Breast Neoplasms (Breast Cancer) 05/2013
1	Leiomyosarcoma 05/2013
1	Infarction (Infarctions) 01/2013
1	Brain Ischemia (Cerebral Ischemia) 01/2013
1	Ischemic Stroke 01/2007
1	Neuroinflammatory Diseases 01/2007

Drug/Important Bio-Agent (IBA)

13	AntibodiesIBA 10/2021 - 02/2014
8	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 11/2019 - 02/2014
6	Proteins (Proteins, Gene)FDA Link 10/2021 - 05/2014
6	AutoantibodiesIBA 04/2019 - 05/2014
4	anti-Yo autoantibodiesIBA 01/2022 - 01/2018
3	Immune Checkpoint InhibitorsIBA 01/2021 - 11/2019
3	ferumoxtran-10 (ultrasmall superparamagnetic iron oxide)IBA 05/2009 - 01/2007
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2015
2	AntigensIBA 01/2022 - 01/2018
2	Leucine (L-Leucine)FDA Link 01/2022 - 10/2021
2	adenylate kinase 5IBA 10/2021 - 01/2017
2	Oligoclonal BandsIBA 10/2021 - 04/2019
2	Immunoglobulin G (IgG)IBA 11/2019 - 12/2015
2	Immunoglobulin A (IgA)IBA 11/2019 - 12/2015
2	AutoantigensIBA 01/2018 - 01/2017
2	Biological ProductsIBA 10/2016 - 05/2013
2	ferric oxide (iron oxide)IBA 01/2013 - 01/2007
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 11/2011 - 12/2010
1	Amyloid beta-PeptidesIBA 01/2022
1	AD 20 (AD-20)IBA 01/2022
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2021
1	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 07/2020
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2020
1	IpilimumabIBA 11/2019
1	pembrolizumabIBA 11/2019
1	NivolumabIBA 11/2019
1	Tripartite Motif ProteinsIBA 04/2019
1	N-Methylaspartate (NMDA)IBA 05/2018
1	Transcription Factors (Transcription Factor)IBA 01/2018
1	Antipsychotic Agents (Antipsychotics)IBA 10/2016
1	Surface Antigens (Surface Antigen)IBA 01/2016
1	AMPA Receptors (AMPA Receptor)IBA 10/2015
1	AcidsIBA 10/2015
1	Progesterone Receptors (Progesterone Receptor)IBA 05/2013
1	FSH Receptors (FSH Receptor)IBA 05/2013
1	Monoclonal AntibodiesIBA 05/2013
1	Estrogen ReceptorsIBA 05/2013
1	Therapeutic UsesIBA 01/2013
1	alpha-internexinIBA 11/2011
1	DNA (Deoxyribonucleic Acid)IBA 12/2010
1	Tissue Plasminogen Activator (Alteplase)FDA Link 10/2009
1	IronIBA 05/2009
1	Pharmaceutical PreparationsIBA 09/2002

Therapy/Procedure

2	Therapeutics 01/2022 - 01/2013
2	Immunotherapy 10/2021 - 01/2017
1	Aftercare (After-Treatment) 11/2019